Adagene Inc (ADAG)
2.48
+0.15
(+6.44%)
USD |
NASDAQ |
May 02, 16:00
2.48
0.00 (0.00%)
After-Hours: 20:00
Adagene Accounts Payable (Quarterly): 3.094M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.094M |
| June 30, 2023 | 4.484M |
| December 31, 2022 | 3.666M |
| June 30, 2022 | 4.666M |
| December 31, 2021 | 3.322M |
| Date | Value |
|---|---|
| June 30, 2021 | 2.834M |
| December 31, 2020 | 1.81M |
| September 30, 2020 | 1.207M |
| December 31, 2019 | 0.7127M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.7127M
Minimum
Dec 2019
4.666M
Maximum
Jun 2022
2.866M
Average
3.094M
Median
Dec 2023
Accounts Payable (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 17.29M |
| CASI Pharmaceuticals Inc | 4.438M |
| Zai Lab Ltd | 112.99M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |